-
Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Average Rating of "Moderate Buy" from Brokerages
来源: Buzz FX / 03 3月 2025 01:36:13 America/Chicago
Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Average Rating of "Moderate Buy" from Brokerages Written by MarketBeat March 3, 2025 Share Link copied to clipboard. Shares of Regulus Therapeutics Inc.
Read more...